Fineotex Chemical FY26 Annual Earnings Summary
3 quarters covered · ₹636 Cr revenue · ₹100 Cr PAT · 18.7% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Risks flagged during the year
Geopolitical tensions and US tariffs have caused postponement of textile orders, affecting revenue conversion.
Q3 FY26 · highTextile recovery hinges on favorable US tariff resolution; any reversal or delay could impact expected order book improvement.
Q2 FY26 · mediumManagement could not provide clarity on warrant conversion status, indicating potential dilution risk.
Q2 FY26 · mediumNew 16,000-tonne plant utilized only ~10% in Q2; full ramp-up may take longer than expected.
Q3 FY26 · mediumCCT was consolidated for only 15 days in Q3; achieving double-digit margins may take longer than expected due to integration complexities.
Q3 FY26 · mediumManagement provided discounts to textile customers during the tariff uncertainty and plans to roll them back from March 2026, which could impact customer retention.
Q3 FY26 · mediumDomestic revenue remained flat YoY at ~₹95.6 crore, indicating limited organic growth in the home market despite new capacity.
Q4 FY26 · mediumWorking capital cycle increased to 79 days (85 days for CCT) due to global logistics disruptions and raw material shortages, which could strain cash flows.
Q4 FY26 · mediumManagement acknowledged container shortages and freight cost increases, which may impact margins if not fully passed through.
Q4 FY26 · mediumCCT's growth is tied to US oil and gas activity; any downturn in drilling or regulatory changes could impact demand.
Q4 FY26 · lowRapid capacity expansion and technology transfer to CCT may face operational hiccups, though management is confident.
What changed through the year
Q2 FY26 · H2 FY26 revenue growth expected to be better than H1
Management expects second half to be stronger than first half, driven by textile recovery and oil & gas ramp-up.
Q2 FY26 · Targeting at least 15% annual growth rate
Management guided for a minimum 15% year-on-year growth rate going forward, assuming geopolitical conditions improve.
Q2 FY26 · Aqua Strike government orders expected in H2
Management is confident of securing significant orders from Indian government for Aqua Strike in the second half of FY26.
Q2 FY26 · EBITDA margin sustainable around 22-23%
Management indicated that historical EBITDA margins average 22-23%, and they expect to maintain similar levels.
Q3 FY26 · FY27 revenue target of ₹1,000 crore+
Management expects consolidated revenue to exceed ₹1,000 crore in the next financial year, driven by CCT full-year contribution and textile recovery.
Q3 FY26 · Oil & gas to contribute 45-50% of revenue
Oil & gas segment (including CCT) is expected to account for 45-50% of total revenue going forward.
Q3 FY26 · CCT margins to improve to double digits
CCT's EBITDA margins, historically around 7-8%, are expected to improve to double digits due to capital infusion and better procurement.
Q3 FY26 · Capex of ₹70-80 crore over 1.5-2 years
Capital expenditure for CCT expansion and other projects is expected to be around ₹70-80 crore (less than $10 million) over the next 1.5-2 years.
Q4 FY26 · CCT revenue target of $200 million by FY28
Management revised the CCT revenue target from 2030 to FY28, with Q4 FY26 as the baseline run-rate of ~$90-100 million.
Q4 FY26 · Consolidated EBITDA margin target of 18-20%
Management expects blended EBITDA margins to improve to 18-20% in the near term, possibly within FY27.
Q4 FY26 · Doubling CCT manufacturing capacity
CCT's manufacturing capacity is being doubled with $7 million capex already deployed; new machines being installed.
Q4 FY26 · Further 25% stake acquisition in CCT by January 2028
Agreement to acquire an additional 25% stake from founders by January 2028, increasing ownership to ~79-80%.